NEW YORK (GenomeWeb) – Helena Biosciences said today that it is collaborating with Ghent University to commercialize a glycoprotein-based blood test for chronic liver disease.

Called the Glyco Liver Profile, the test uses capillary electrophoresis to measure glycosylation of serum proteins, and uses this information to diagnose and monitor chronic liver diseases such as hepatic inflammation, fibrosis, and cirrhosis. The test also assesses cirrhosis patients' risk of developing liver cancer within the next five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Oct
10
Sponsored by
PerkinElmer

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.